Cardiovascular toxicity of abacavir-Reference-Cited by-同舟云学术

Cardiovascular toxicity of abacavir

Published:2017-08-24 Issue:13 Volume:31 Page:1781-1795
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Alvarez Angeles,Orden Samuel,Andújar Isabel,Collado-Diaz Victor,Núñez-Delgado Sara,Galindo Maria J.,Estrada Vicente,Apostolova Nadezda,Esplugues Juan V.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference80 articles.

1. Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed JIV-infected patients: role of antiretroviral therapy;Masiá;AIDS,2013

2. HIV infection and the risk of acute myocardial infarction;Freiberg;JAMA Intern Med,2013

3. Inflammation, immune activation, and CVD risk in individuals with HIV infection;Stein;JAMA,2012

4. State of the science conference: initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary;Grinspoon;Circulation,2008

5. Combination antiretroviral therapy and the risk of myocardial infarction;Friis-Moller;N Engl J Med,2003

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Lamivudine and Dolutegravir simplification therapy compared with triple therapy in Northeast Brazil (LAMDO Study);Journal of HIV for Clinical and Scientific Research;2024-02-06

2. Chronic and Other Conditions That Increase CVD Risk;Preventive Cardiovascular Nursing;2024

3. Comparing implications of cardiovascular risk of abacavir and integrase inhibitors: why scientific community is confused and timid?;AIDS;2023-05-01

4. Changes in Coagulation and Platelet Reactivity in People with HIV-1 Switching Between Abacavir and Tenofovir;The Open AIDS Journal;2022-09-20

5. Abacavir antiretroviral therapy and indices of subclinical vascular disease in persons with HIV;PLOS ONE;2022-03-10